Praziquantel target validation of a Ca2+ permeable channel in schistosomes
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column width="2/3"][vc_column_text]Highlights Schistosomiasis is a devastating neglected helminthic disease. Praziquantel (PZQ) is the most important drug against schistosomiasis. Previous work identified a TRP channel of the melastatin type as a PZQ target. Molecular studies now reveal the basis...